Synthaverse S.A. (WSE:SVE)
Poland
· Delayed Price · Currency is PLN 3.590
-0.010 (-0.28%)
Mar 9, 2026, 5:00 PM CET
Synthaverse Revenue
In the year 2024, Synthaverse had annual revenue of 71.76M PLN with 22.44% growth. Synthaverse had revenue of 4.79M in the quarter ending September 30, 2025, a decrease of -64.28%.
Revenue
71.76M
Revenue Growth
+22.44%
P/S Ratio
3.54
Revenue / Employee
300.23K
Employees
239
Market Cap
254.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 71.76M | 13.15M | 22.44% |
| Dec 31, 2023 | 58.61M | 8.22M | 16.32% |
| Dec 31, 2022 | 50.38M | 9.23M | 22.43% |
| Dec 31, 2021 | 41.15M | 995.00K | 2.48% |
| Dec 31, 2020 | 40.16M | 1.05M | 2.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 282.52M |
| Molecure | 5.86M |
| Captor Therapeutics Spolka Akcyjna | 7.57M |
| Mabion | 14.81M |
| Poltreg | 250.00K |
| Ryvu Therapeutics | 90.41M |
| NanoGroup | -6.90K |
| Urteste | 1.80M |